Study of Irofulven in Patients With Hormone-refractory Prostate Cancer

Clinical trial NCT00124566 · COMPLETED

Trial details

NCT number: NCT00124566
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2004-06-01
Primary completion: 2006-01-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.